pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
ABBVIE · news · pharmadog
← back to ABBVIE
News mentioning ABBVIE
74
stories
May 29, 26
Allogene CEO to step down; Agios drug fails key test
biopharma dive
May 28, 26
AbbVie clinches FDA approval for ultra-rare blood cancer ADC from ImmunoGen purchase
endpoints
May 15, 26
Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
biopharma dive
May 14, 26
BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta
endpoints
May 6, 26
Amgen, AbbVie say IRA negotiations impacted Q1 sales
endpoints
May 6, 26
Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer
onclive
May 1, 26
Opinion: The psychedelic revolution is leaving behind people of color
stat
Apr 29, 26
AbbVie faces questions about Skyrizi competition from J&J
endpoints
Apr 29, 26
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
biopharma dive
Apr 29, 26
STAT+: A patent win for Pfizer and BridgeBio
stat
Apr 28, 26
Updated: AbbVie flirts with popular pan-RAS field in up to $1.45B option to acquire Kestrel
endpoints
Apr 27, 26
Oruka surges as long-acting psoriasis drug shows early promise
biopharma dive
Apr 22, 26
AbbVie's $1.4B North Carolina manufacturing site to finish during Trump's term
endpoints
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77M
fiercebiotech
← prev
page 3 of 3
next →
